Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

AS Ashley James posted pics onto her social media, enjoying a sun-soaked trip and wearing nothing but a bikini, the ...

GLP-1RA medications in preadolescents and adolescents were concentrated among those with diabetes, obesity, mood disorders, and anxiety.

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

This new Liraglutide injection is a generic equivalent for Victoza, which is a once-daily noninsulin medicine that lowers ...

The following is a summary of “Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and ...

Here are six new shortages and discontinuations for April, according to drug supply databases from the FDA and the American ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...